Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Coulter

Showing results (41-50 of 149) with videos related to

Pageof 15
Sort By:
Pediatrics|February 1, 1980
Increased lead absorption in inner city children: where does the lead come from?E Charney, J Sayre, M Coulter
The New Zealand Medical Journal|June 28, 1989
ACE inhibitors and anaemiaI R Edwards, D M Coulter
The Primary Care Companion for CNS Disorders|May 1, 2026
Prognostic Implications of Catatonia in End-of-Life Care for Patients With Advanced Neurocognitive DisorderAndrew M Coulter, Gregg A Robbins-Welty
Expert Opinion on Drug Safety|October 27, 2004
Disturbance of vision by COX-2 inhibitorsDavid M Coulter, David W J Clark
Advances in Experimental Medicine and Biology|January 1, 1981
Assembly of mouse hepatitis virus strain JHMA Massalski, M Coulter-Mackie, S Dales
Pharmacoepidemiology and Drug Safety|August 6, 2003
Use of the New Zealand Intensive Medicines Monitoring Programme to study the levonorgestrel-releasing intrauterine device (Mirena)Lifeng Zhou, Mira Harrison-Woolrych, David M Coulter
BMJ (Clinical Research Ed.)|February 8, 1992
Intestinal effects of captoprilI R Edwards, D M Coulter, D Macintosh
Brain Research. Molecular Brain Research|December 1, 1994
Localization of RC3 (neurogranin) in rat brain subcellular fractionsJ B Watson, I Szijan, P M Coulter
The New Zealand Medical Journal|January 26, 1994
Interaction of phenytoin and fluoxetineD J Woods, D M Coulter, P Pillans
European Journal of Clinical Pharmacology|January 1, 1996
Angiooedema and urticaria with angiotensin converting enzyme inhibitorsP I Pillans, D M Coulter, P Black
Pageof 15

Showing results (41-50 of 149) with videos related to

Sort By:
Pageof 15
Pediatrics|February 1, 1980
Increased lead absorption in inner city children: where does the lead come from?E Charney, J Sayre, M Coulter
The New Zealand Medical Journal|June 28, 1989
ACE inhibitors and anaemiaI R Edwards, D M Coulter
The Primary Care Companion for CNS Disorders|May 1, 2026
Prognostic Implications of Catatonia in End-of-Life Care for Patients With Advanced Neurocognitive DisorderAndrew M Coulter, Gregg A Robbins-Welty
Expert Opinion on Drug Safety|October 27, 2004
Disturbance of vision by COX-2 inhibitorsDavid M Coulter, David W J Clark
Advances in Experimental Medicine and Biology|January 1, 1981
Assembly of mouse hepatitis virus strain JHMA Massalski, M Coulter-Mackie, S Dales
Pharmacoepidemiology and Drug Safety|August 6, 2003
Use of the New Zealand Intensive Medicines Monitoring Programme to study the levonorgestrel-releasing intrauterine device (Mirena)Lifeng Zhou, Mira Harrison-Woolrych, David M Coulter
BMJ (Clinical Research Ed.)|February 8, 1992
Intestinal effects of captoprilI R Edwards, D M Coulter, D Macintosh
Brain Research. Molecular Brain Research|December 1, 1994
Localization of RC3 (neurogranin) in rat brain subcellular fractionsJ B Watson, I Szijan, P M Coulter
The New Zealand Medical Journal|January 26, 1994
Interaction of phenytoin and fluoxetineD J Woods, D M Coulter, P Pillans
European Journal of Clinical Pharmacology|January 1, 1996
Angiooedema and urticaria with angiotensin converting enzyme inhibitorsP I Pillans, D M Coulter, P Black
Pageof 15